Nicardipinum [Inn-Latin] en es it fr

Nicardipinum [Inn-Latin] Brand names, Nicardipinum [Inn-Latin] Analogs

Nicardipinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Nicardipinum [Inn-Latin] Chemical_Formula


Nicardipinum [Inn-Latin] RX_link

Nicardipinum [Inn-Latin] fda sheet

Nicardipinum_[Inn-Latin] FDA

Nicardipinum [Inn-Latin] msds (material safety sheet)

Nicardipinum_[Inn-Latin] MSDS

Nicardipinum [Inn-Latin] Synthesis Reference

No information avaliable

Nicardipinum [Inn-Latin] Molecular Weight

479.525 g/mol

Nicardipinum [Inn-Latin] Melting Point

136-138 oC

Nicardipinum [Inn-Latin] H2O Solubility

2.2 mg/L

Nicardipinum [Inn-Latin] State


Nicardipinum [Inn-Latin] LogP


Nicardipinum [Inn-Latin] Dosage Forms


Nicardipinum [Inn-Latin] Indication

Used for the management of patients with chronic stable angina and for the treatment of hypertension.

Nicardipinum [Inn-Latin] Pharmacology

Nicardipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nicardipine is similar to other peripheral vasodilators. Nicardipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Nicardipinum [Inn-Latin] Absorption

While nicardipine is completely absorbed, it is subject to saturable first pass metabolism and the systemic bioavailability is about 35% following a 30 mg oral dose at steady state.

Nicardipinum [Inn-Latin] side effects and Toxicity

Oral LD50 Rat = 184 mg/kg, Oral LD50 Mouse = 322 mg/kg

Nicardipinum [Inn-Latin] Patient Information

No information avaliable

Nicardipinum [Inn-Latin] Organisms Affected

Humans and other mammals